JINS HOLDINGS (3046) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Net sales for the three months ended November 30, 2024, rose 15.9% year-over-year to ¥21,056 million, driven by new store openings and strong product performance.
Operating profit increased 83.8% year-over-year to ¥2,003 million, and profit attributable to owners of parent surged 127.3% to ¥1,317 million.
Domestic eyewear business saw robust growth, with net sales up 19.0% and segment operating profit up 97.6% year-over-year.
Overseas eyewear business achieved 7.0% sales growth and a 33.1% increase in segment operating profit, with recovery in China and strong performance in Taiwan.
Financial highlights
Gross profit for the quarter was ¥16,606 million, up from ¥14,347 million year-over-year.
Ordinary profit reached ¥2,002 million, up 89.5% year-over-year.
EPS for the quarter was ¥56.44, more than double the ¥24.83 from the prior year.
Comprehensive income increased 109.4% year-over-year to ¥1,065 million.
Outlook and guidance
Full-year forecast for FY2025 projects net sales of ¥90,100 million (up 8.6%), operating profit of ¥8,500 million (up 8.5%), and profit attributable to owners of parent of ¥5,230 million (up 11.9%).
No changes to previously announced forecasts; forward-looking statements are subject to risks from economic and market fluctuations.
Latest events from JINS HOLDINGS
- Profits nearly doubled on strong domestic sales and overseas recovery, with a positive full-year outlook.3046
Q3 20259 Jan 2026 - Strong sales growth and overseas expansion drive higher profits, with stable full-year outlook.3046
Q1 20269 Jan 2026 - Record sales and profit growth, with double-digit expansion and global investments planned.3046
Q4 202510 Oct 2025 - Record profits and domestic growth drive global expansion despite overseas challenges.3046
Q4 202413 Jun 2025 - Strong sales and profit growth driven by domestic expansion, with raised full-year outlook.3046
Q3 202413 Jun 2025 - Sales and profits surged, prompting upward revisions to full-year outlook and dividends.3046
Q2 20256 Jun 2025